Loading
CI
Cybin Inc. (formerly, Clarmin Explorations Inc.) Stock: price and insider trades · Canada
Cybin Inc. (formerly, Clarmin Explorations Inc.): what insiders have been doing
This page follows insider dealings at Cybin Inc. (formerly, Clarmin Explorations Inc.) as filed with SEDI. The past year has been quiet: not a single insider filing for Cybin Inc. (formerly, Clarmin Explorations Inc.). The previous disclosure was published on 3 September 2025.
Since 2020, the database holds 18 purchases and 1 sale by insiders of the company.
Source: insider filings from SEDI. Past trades are no guide to future returns.
Insider Decl.
33
Thresholds
n/a
Buy Volume
€363,717
18 ops. · all time
Sell Volume
n/a
1 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 3 September 2025
Declarations33 total
2,500 shares@ CA$1.8511.1% of flowCommon SharesTSXSEDI:3835303
Canonical exit: 17 Feb 2022 (T+90)
5,000 shares@ CA$1.8722.4% of flowCommon SharesTSXSEDI:3835302
Canonical exit: 17 Feb 2022 (T+90)
25,000 shares@ CA$1.6012.5% of flowCommon SharesTSXSEDI:3710020
Canonical exit: 17 Jun 2021 (T+90)
5,000 shares@ CA$2.003.0% of flowCommon SharesTSXSEDI:3684735
Canonical exit: 19 May 2021 (T+90)
5,000 shares@ CA$2.013.1% of flowCommon SharesTSXSEDI:3684739
Canonical exit: 19 May 2021 (T+90)
1,200 shares@ CA$2.500.9% of flowCommon SharesTSXSEDI:3790731
Canonical exit: 15 Nov 2021 (T+90)
380,230 sharesCommon SharesTSXSEDI:3943920
Common SharesTSXSEDI:3943918
43,570 sharesCommon SharesTSXSEDI:3936914
Canonical exit: 28 Jul 2022 (T+90)
Common SharesTSXSEDI:3913351
38,000 shares@ CA$0.80100.0% of flowCommon SharesTSXSEDI:3913369
Canonical exit: 22 Jun 2022 (T+90)
25,000 shares@ CA$1.009.5% of flowCommon SharesTSXSEDI:3913377
Canonical exit: 22 Jun 2022 (T+90)
20,000 sharesCommon SharesTSXSEDI:3895440
59,999 shares@ CA$1.6297.7% of flowCommon SharesTSXSEDI:3835666
Canonical exit: 20 Feb 2022 (T+90)
15,000 shares@ CA$1.8566.5% of flowCommon SharesTSXSEDI:3835306
Canonical exit: 17 Feb 2022 (T+90)
1,000 shares@ CA$2.352.3% of flowCommon SharesTSXSEDI:3809274
Canonical exit: 26 Dec 2021 (T+90)
Common SharesTSXSEDI:3792498
25,000 shares@ CA$2.3017.9% of flowCommon SharesTSXSEDI:3792504
Canonical exit: 17 Nov 2021 (T+90)
5,000 shares@ CA$2.303.6% of flowCommon SharesTSXSEDI:3792505
Canonical exit: 17 Nov 2021 (T+90)
20,000 shares@ CA$2.23100.0% of flowCommon SharesTSXSEDI:3792500
Canonical exit: 17 Nov 2021 (T+90)
Common SharesTSXSEDI:3790736
9,000 shares@ CA$2.507.1% of flowCommon SharesTSXSEDI:3790730
Canonical exit: 15 Nov 2021 (T+90)
50,000 shares@ CA$2.5239.7% of flowCommon SharesTSXSEDI:3790740
Canonical exit: 15 Nov 2021 (T+90)
5,000 shares@ CA$2.023.8% of flowCommon SharesTSXSEDI:3684748
Canonical exit: 19 May 2021 (T+90)
82,883 sharesCommon SharesTSXSEDI:3643019
25 of 33 declarations
About Cybin Inc. (formerly, Clarmin Explorations Inc.)
Cybin Inc. is a biopharmaceutical company focused on developing psychedelic therapies for mental health disorders. Formerly known as Clarmin Explorations Inc., it is listed on the XTSE.
